Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities (SIMULA)

December 19, 2025 updated by: Istituto Ortopedico Rizzoli

Virtual Surgical Planning (VSP), Computer-Aided Surgical Simulation (CASS) for bone corrections, and the customization of implants and devices through 3D printing, known as Patient-Specific Instruments (PSI) and Graft-Specific Instruments (GSI), are assuming increasingly central roles in orthopedic clinical and surgical practice.

One area witnessing notable advancement is the treatment of musculoskeletal disorders (MMS) in children, adolescents, and young adults. These disorders involve severe and rare abnormalities in skeletal formation and development across three-dimensional planes, often affecting multiple limbs. Managing such deformities is complex, challenging to standardize, and prone to unpredictable clinical, radiographic, and functional outcomes.

The application of 3D modeling and printing technologies offers a deeper understanding of deformities and facilitates improved prediction, precision, reproducibility, and safety in surgical interventions.

The Musculoskeletal Apparatus Network (RAMS Network) centers are equipped with advanced 3D laboratories for surgical simulation and planning, aligned with the overarching goal of improving surgery quality through "in-silico" medicine (ISM) principles.

At present, numerous complex surgeries involving Virtual Surgical Planning (VSP) and sterilizable 3D-printed Patient-Specific Instruments (PSI) and/or Graft-Specific Instruments (GSI) are being simulated and performed at the Rizzoli Institute. Preliminary data from previous protocols indicate a significant reduction in surgical time with the implementation of VSP and the utilization of PSI and GSI.

The aim of this study is to enhance the current process of simulating, planning, and designing surgical support tools within 3D Printing Point-of-Care (3D POC) facilities. To achieve this, it is imperative to expand case volumes and systematically organize, categorize, and standardize simulation and planning procedures.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Genova, Italy
      • Milan, Italy
      • Pavia, Italy
        • Not yet recruiting
        • Policlinico San Matteo
        • Contact:
          • Gianluigi Pasta, MD
      • Roma, Italy
        • Not yet recruiting
        • Istituto Nazionale Tumori Regina Elena
        • Contact:
      • Roma, Italy
    • BO
      • Bologna, BO, Italy, 40136
        • Recruiting
        • IRCCS Istituto Ortopedico Rizzoli
        • Contact:
    • MI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosis of musculoskeletal disease (MSD) of the limbs;
  • Need for mono- or polyaxial correction by one or more osteotomies;
  • Presence of specific consent to participate in the trial;

Exclusion Criteria:

  • Patients who refuse to participate in the study
  • Patients who do not undergo radiological follow-up examinations for VSP or for whom the radiological record is insufficient to conduct VSP;
  • Patients who undergo different interventions for correction of MSD (growth modulation interventions by epiphysiodesis and hemiepiphysiodesis, progressive correction by external circular/hexapodal fixation);
  • Pregnant or lactating women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pediatric patients with musculoskeletal diseases
Children, adolescents, and young adults suffering from musculoskeletal disorders (MMD) who exhibit complex conditions characterized by rare and severe anomalies in skeletal development. These abnormalities may affect bones, joints, and musculotendinous structures.
Surgeries to correct bone defomity, supported by the use of preoperative planning and/or patient-specific instruments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Achieved skeletal corrections
Time Frame: At baseline (day 0)
Assessment of achieved skeletal corrections compared to planned corrections, measured on standard radiographs or CT scans depending on the type of deformity corrected
At baseline (day 0)
Achieved skeletal corrections
Time Frame: After 1 year
Assessment of achieved skeletal corrections compared to planned corrections, measured on standard radiographs or CT scans depending on the type of deformity corrected
After 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Operating room times
Time Frame: At baseline (day 0)
Operating room times for each planned procedure
At baseline (day 0)
Fluoroscopy times
Time Frame: At baseline (day 0)
Fluoroscopy times for each planned procedure
At baseline (day 0)
Blood loss
Time Frame: At baseline (day 0)
Blood loss for each patient
At baseline (day 0)
Intra- and peri-operative complications
Time Frame: At baseline (day 0)
Intra- and peri-operative complications for each patient
At baseline (day 0)
Suitability of PSIs
Time Frame: At baseline (day 0)
Suitability of PSIs in relation to the planned surgery
At baseline (day 0)
Suitability of GSIs
Time Frame: At baseline (day 0)
Suitability of GSIs, if needed, in relation to the planned surgery
At baseline (day 0)
Suitability of bone graft
Time Frame: At baseline (day 0)
Suitability of bone graft, if needed, in relation to the planned surgery
At baseline (day 0)
Clinical-functional outcome
Time Frame: At baseline (day 0)
Clinical-functional outcome will be assessed by preoperative and one-year follow-up administration of the Pediatric Outcome Data Collection Instrument (PODCI) questionnaire for pediatric patients or the Short Form Health Survey 36 (SF-36) for young adults
At baseline (day 0)
Clinical-functional outcome
Time Frame: After 1 year
Clinical-functional outcome will be assessed by preoperative and one-year follow-up administration of the Pediatric Outcome Data Collection Instrument (PODCI) questionnaire for pediatric patients or the Short Form Health Survey 36 (SF-36) for young adults
After 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost analysis
Time Frame: At baseline (day 0)
The cost analysis will entail evaluating expenses associated with various components, including imaging required for planning, production of 3D-printed instrumentation such as PSIs and GSIs, and bone grafts. Additionally, human costs for planning will be considered. Surgical-related costs will be assessed by comparing them with those of traditional surgeries to gauge the cost-effectiveness of the procedure, taking into account the achieved correction and the necessity for additional procedures.
At baseline (day 0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierfrancesco Costici, MD, Ospedale Pediatrico Bambin Gesù
  • Principal Investigator: Giorgio Marrè Brunenghi, MD, Istituto Giannina Gaslini
  • Principal Investigator: Fabio Verdoni, MD, Galeazzi Orthopedic Institute
  • Principal Investigator: Roberto Biagini, MD, Istituto Nazionale Tumori Regina Elena
  • Principal Investigator: Gianluigi Pasta, MD, Policlinico San Matteo
  • Principal Investigator: Tommaso Bonanzinga, MD, Istituto Clinico Humanitas

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 31, 2024

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2029

Study Registration Dates

First Submitted

April 18, 2024

First Submitted That Met QC Criteria

April 23, 2024

First Posted (Actual)

April 24, 2024

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 19, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe